✦ LIBER ✦

Chemical genomics versus orthodox drug development

✍ Scribed by David E. Szymkowski

Book ID: 114384274
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 37 KB
Volume: 8
Category: Article
ISSN: 1359-6446
DOI: 10.1016/s1359-6446(03)02599-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genomics and Cardiovascular Drug Develop

Genomics and Cardiovascular Drug Development

✍ Andrew S. Plump; Pek Yee Lum 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 945 KB

Chemical ligands, genomics and drug disc

Chemical ligands, genomics and drug discovery

✍ George R Lenz; Huw M Nash; Satish Jindal 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 658 KB

Expression genomics and cancer drug deve

Expression genomics and cancer drug development

✍ Edison T. Liu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Impact of genomics on therapeutic drug d

Impact of genomics on therapeutic drug development

✍ Giulia C. Kennedy 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 3 views

Genomics is defined as a set of related technologies which are focused on the discovery of genes implicated in human disease. Although many of the estimated 100,000 genes in the human genome have been at least partially identified by nucleotide sequence, elucidation of biological function has been a

6 Genomics and proteomics in drug develo

6 Genomics and proteomics in drug development

✍ P. Workman 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Progress in applying genomics in drug de

Progress in applying genomics in drug development

✍ Peter G Lord 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB